Skip to main content

Join us and gain deeper insights into Revvity’s strategic direction, operational achievements, and future growth prospects – including our unique position where we help bridge the gap between helping unlock novel preclinical discoveries resulting in improved clinical outcomes for our customers and patients.

Agenda

8:00 AM - 9:00 AM PT
Registration and Breakfast
9:00 AM - 10:00 AM PT
Formal Presentations
10:00 AM - 10:30 AM PT
Q&A Session and Break
10:30 AM - 12:00 PM PT
Formal Presentations
12:00 PM - 12:30 PM PT
Q&A and Wrap Up

Speakers

2023 Financial
Highlights

$2.8

Billion total revenue

~80%

Recurring revenue

61.5%

Gross margin

28%

Adjusted operating margins